FCX vs PYXS · P/E 38, rev $13.26B vs rev $2.8M
Freeport-McMoran Copper & Gold Inc (FCX) versus Pyxis Oncology Inc (PYXS) — a side-by-side from cached financials, not a winner call.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
Latest reported FCX revenue for 2026-06-30 was $13.26B. Net income was $1.86B. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
FCX currently screens at market cap $67.80B and trailing P/E 38.0. PYXS currently screens at market cap $109.6M.
Not investment advice. Open the FCX and PYXS stock pages for the full models.
Not investment advice.